Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines)-Reference-Cited by-同舟云学术

Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines)

Published:2023-03-10 Issue:5 Volume:53 Page:383-390
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatology Research

Author:

Hasegawa Kiyoshi¹^ORCID,Takemura Nobuyuki²^ORCID,Yamashita Tatsuya³,Watadani Takeyuki⁴^ORCID,Kaibori Masaki⁵,Kubo Shoji⁶,Shimada Mitsuo⁷,Nagano Hiroaki⁸^ORCID,Hatano Etsuro⁹^ORCID,Aikata Hiroshi¹⁰,Iijima Hiroko¹¹,Ueshima Kazuomi¹²^ORCID,Ohkawa Kazuyoshi¹³^ORCID,Genda Takuya¹⁴^ORCID,Tsuchiya Kaoru¹⁵,Torimura Takuji¹⁶,Ikeda Masafumi¹⁷^ORCID,Furuse Junji¹⁸,Akahane Masaaki¹⁹,Kobayashi Satoshi²⁰^ORCID,Sakurai Hideyuki²¹,Takeda Atsuya²²,Murakami Takamichi²³^ORCID,Motosugi Utaroh²⁴,Matsuyama Yutaka²⁵,Kudo Masatoshi¹²,Tateishi Ryosuke²⁶,

Affiliation:

1. Hepato‐Biliary‐Pancreatic Surgery Division Department of Surgery Graduate School of Medicine University of Tokyo Tokyo Japan

2. Department of Surgery Hepato‐Biliary Pancreatic Surgery Division National Center for Global Health and Medicine Tokyo Japan

3. Department of Gastroenterology Kanazawa University Hospital Kanazawa Japan

4. Department of Radiology Graduate School of Medicine The University of Tokyo Tokyo Japan

5. Department of Surgery Hirakata Hospital Kansai Medical University Hirakata Japan

6. Department of Hepato‐Biliary‐Pancreatic Surgery Osaka Metropolitan University Graduate School of Medicine Osaka Japan

7. Department of Digestive and Transplant Surgery Tokushima University Hospital Tokushima Japan

8. Department of Gastroenterological, Breast and Endocrine Surgery Yamaguchi University Graduate School of Medicine Yamaguchi Japan

9. Division of Hepato‐Biliary‐Pancreatic Surgery and Transplantation Department of Surgery Graduate School of Medicine Kyoto University Kyoto Japan

10. Department of Medicine and Molecular Science Hiroshima University Hospital Hiroshima Japan

11. Division of Gastroenterology and Hepatobiliary Department of Internal Medicine Hyogo Medical University Nishinomiya Japan

12. Department of Gastroenterology and Hepatology Kindai University Faculty of Medicine Higashi‐osaka Japan

13. Department of Hepatobiliary and Pancreatic Oncology Osaka International Cancer Institute Osaka Japan

14. Department of Gastroenterology and Hepatology Juntendo University Shizuoka Hospital Izunokuni Japan

15. Department of Gastroenterology and Hepatology Musashino Red Cross Hospital Musashino Japan

16. Division of Gastroenterology Department of Medicine Kurume University School of Medicine Kurume Japan

17. Department of Hepatobiliary and Pancreatic Oncology National Cancer Center Hospital East Kashiwa Japan

18. Department of Gastroenterology Kanagawa Cancer Center Yokohama Japan

19. Department of Radiology School of Medicine International University of Health and Welfare Otawara Japan

20. Department of Quantum Medical Technology Kanazawa University Graduate School of Medical Sciences Kanazawa Japan

21. Department of Radiation Oncology University of Tsukuba Faculty of Medicine Tsukuba Japan

22. Radiation Oncology Center Ofuna Chuo Hospital Kamakura Japan

23. Department of Radiology Kobe University Graduate School of Medicine Hyogo Japan

24. Department of Diagnostic Radiology Kofu Kyoritsu Hospital Kofu Japan

25. Department of Biostatistics School of Public Health Graduate School of Medicine The University of Tokyo Tokyo Japan

26. Department of Gastroenterology Graduate School of Medicine The University of Tokyo Tokyo Japan

Abstract

AbstractThe fifth version of the Clinical Practice Guidelines for Hepatocellular Carcinoma was revised by the Japan Society of Hepatology, according to the methodology of evidence‐based medicine and partly to the Grading of Recommendations Assessment, Development and Evaluation system, which was published in October 2021 in Japanese. In addition to surveillance–diagnostic and treatment algorithms, a new algorithm for systemic therapy has been created, as multiple drugs for hepatocellular carcinoma can be currently selected. Here, new or revised algorithms and evidence on which the recommendations are based are described.

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.13892

Reference20 articles.

1. Clinical practice guidelines for hepatocellular carcinoma: the first evidence based guidelines from Japan

2. Clinical practice guidelines for hepatocellular carcinoma – The Japan Society of Hepatology 2009 update;Makuuchi M;Hepatol Res,2010

3. Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines)

4. Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Trends on the Involvement of Zinc, Copper, and Selenium in the Process of Hepatocarcinogenesis;Nutrients;2024-02-06

2. Impact of the COVID‐19 pandemic on the number and short‐term outcomes in hepatectomy for hepatocellular carcinoma: Results from the Japanese National Clinical Database, 2018–2021;Hepatology Research;2024-02-03

3. The impact of COVID-19 on the diagnosis and treatment of HCC: analysis of a nationwide registry for advanced liver diseases (REAL);Scientific Reports;2024-02-03

4. Utilization of muscle area in an accurate prediction formula for renal function for patients with hepatocellular carcinoma;Asian Journal of Surgery;2024-02

5. A patient alive without disease 32 months after conversion surgery following lenvatinib treatment for hepatocellular carcinoma with a tumor thrombus originating in the middle hepatic vein and reaching the right atrium via the suprahepatic vena cava: a case report;Clinical Journal of Gastroenterology;2024-01-26